Key Takeaways

  • Success rates: Equal or better than fresh transfer. 50-65% for PGT-A euploid blastocysts.
  • Vitrification survival: 95-99% of embryos survive thawing. Modern vitrification is remarkably reliable.
  • Two protocols: Medicated (hormone replacement) or natural cycle. Both achieve equivalent outcomes.
  • Timeline: Medicated FET: ~3-4 weeks preparation + transfer. Natural cycle: depends on ovulation timing.
  • Key advantage: Separating stimulation from transfer allows the body to recover, avoids OHSS risk, and enables PGT testing.

A frozen embryo transfer (FET) is the process of thawing a previously vitrified embryo and transferring it to the uterus in a subsequent menstrual cycle - separate from the ovarian stimulation and egg retrieval cycle. This approach has several significant advantages over fresh embryo transfer and has become the dominant strategy at leading fertility centers worldwide.

Why Freeze-All?

The shift from fresh to frozen transfer is driven by three factors:

The FET Process

Option 1: Medicated (Hormone Replacement) FET

The most commonly used protocol:

  1. Day 1-2 of period: Baseline ultrasound and blood work to confirm no residual cysts or issues.
  2. Days 1-14: Oral or transdermal estrogen (estradiol) to build the endometrial lining. Target: ≥7 mm thickness with trilaminar (triple-line) pattern on ultrasound.
  3. Day ~14: Lining check ultrasound. If adequate, progesterone is initiated.
  4. Progesterone days 1-5: Intramuscular or vaginal progesterone transforms the endometrium from proliferative to secretory phase - creating the implantation window.
  5. Day 5 of progesterone: Embryo thaw and transfer. A vitrified blastocyst is warmed (2-3 minutes), assessed for survival (95-99% survive), and transferred to the uterus via a thin catheter under ultrasound guidance. The procedure takes 5-10 minutes and is painless.
  6. Post-transfer: Continue estrogen and progesterone. Pregnancy test (beta-hCG blood test) at 10-12 days post-transfer.

Option 2: Natural Cycle FET

For women with regular ovulatory cycles:

  1. Monitor natural follicle development and ovulation via ultrasound and blood tests (LH surge)
  2. Transfer timed to 5 days after ovulation (for blastocysts) or 3 days after ovulation (for Day 3 embryos)
  3. No or minimal exogenous hormones - progesterone supplementation may or may not be added

Natural cycle FET produces equivalent success rates to medicated cycles in women with reliable ovulation but requires more monitoring visits to capture the ovulation window precisely.

ERA Testing: Personalizing Transfer Timing

ERA (Endometrial Receptivity Analysis) is a molecular test that determines each woman's personal "window of implantation" - the specific hours during which the endometrium is most receptive to embryo attachment. Approximately 25% of women with recurrent implantation failure have a displaced window - meaning the standard Day 5 progesterone timing doesn't match their individual biology.

ERA involves a mock transfer cycle with a small endometrial biopsy analyzed for gene expression patterns. The results shift the transfer timing by 12-24 hours in either direction. Studies show ERA-guided transfers improve implantation rates in patients with previous failures.

Success Rates

At Wholecares partner IVF centers, FET is performed using vitrification technology with 97-99% embryo survival rates. Both medicated and natural cycle protocols are offered, with ERA testing available for patients with previous implantation failure. Transparent pricing for FET cycles includes monitoring, embryo thaw, transfer, and progesterone support.